e-learning
resources
Virtual 2020
Pre-Congress Content
Inhaled corticosteroids and bronchodilator studies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adhesion to inhaled treatment in patients with asthma and COPD
J. Hernandez Borge (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), M. Gómez Vizcaino (Badajoz, Spain), S. Hernández Gómez (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain)
Source:
Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Session:
Inhaled corticosteroids and bronchodilator studies in asthma
Session type:
E-poster session
Number:
2645
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Hernandez Borge (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), M. Gómez Vizcaino (Badajoz, Spain), S. Hernández Gómez (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain). Adhesion to inhaled treatment in patients with asthma and COPD. 2645
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Adherence of stable COPD patients to inhaled pharmacotherapy
Source: Annual Congress 2011 - COPD management
Year: 2011
Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010
Inhaled medication use in asthma and COPD Roma/Gypsies patients
Source: Eur Respir J 2005; 26: Suppl. 49, 610s
Year: 2005
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Obesity and the response to inhaled budesonide in patients with asthma
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004
Restoring corticosteroid sensitivity in COPD and smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008
Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
The adherence to inhaled drugs in COPD patients: Effect on survival
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
The role of nebulised budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2007; 30: 399-400
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept